Careplus Berhad vs Humana

Careplus Berhad is a Malaysian-based healthcare company focusing on the production and distribution of medical gloves, while Humana is a US-based health insurance company providing a range of healthcare services. Both companies operate in the healthcare industry, but their business models and geographical presence differ significantly. Careplus Berhad's stock performance may be impacted by global demand for medical gloves, while Humana's stock may be influenced by changes in the US healthcare system. Investors should consider these factors when evaluating the potential risks and rewards of investing in Careplus Berhad vs Humana stocks.

Careplus Berhad or Humana?

When comparing Careplus Berhad and Humana, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Careplus Berhad and Humana.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Careplus Berhad has a dividend yield of -%, while Humana has a dividend yield of 1.37%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Careplus Berhad reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Humana reports a 5-year dividend growth of 12.10% year and a payout ratio of 25.48%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Careplus Berhad P/E ratio at -6.21 and Humana's P/E ratio at 18.13. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Careplus Berhad P/B ratio is 0.58 while Humana's P/B ratio is 1.86.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Careplus Berhad has seen a 5-year revenue growth of -0.81%, while Humana's is 1.07%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Careplus Berhad's ROE at -9.83% and Humana's ROE at 10.37%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are RM0.26 for Careplus Berhad and $251.24 for Humana. Over the past year, Careplus Berhad's prices ranged from RM0.25 to RM0.51, with a yearly change of 104.00%. Humana's prices fluctuated between $213.31 and $530.54, with a yearly change of 148.72%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.